SAMBA II SARS-CoV-2 Test
In vitro nucleic acid amplification test for the qualitative detection of SARs-CoV-2 in human nasal and throat swabs.
The SAMBA II Coronavirus SARS-CoV-2 Test system (P/N 8500) is designed to specifically detect the presence of the novel coronavirus, SARS-CoV-2, in nose and throat swab samples run on the SAMBA II instrument.
The test specifically amplifies and detects two regions of the SARS-CoV-2 genome in the ORF1ab (region 1) and nucleoprotein (region 2), reported as two distinct lines on the test strip. A third line on the test strip, the internal control, is present to control for false negatives caused by instrument/reagent problems or inhibition.